Ipilimumab and Nivolumab in Leptomeningeal Metastases

NCT02939300 PHASE2 COMPLETED Results posted

This research study is studying a combination of two drugs as a possible treatment for Leptomeningeal Metastases. The names of the study interventions involved in this study are: * Ipilimumab * Nivolumab

Details

Lead sponsor	Massachusetts General Hospital
Phase	PHASE2
Status	COMPLETED
Enrolment	18
Start date	Thu Feb 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Jul 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Leptomeningeal Carcinomatosis

Interventions

• Nivolumab
• Ipilimumab

Countries

United States